Cambridge Investment Research Advisors
ADNT icon

Cambridge Investment Research Advisors’s Adient ADNT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,645
Closed -$647K – 3312
2024
Q1 		$647K Buy
+19,645
New +$669K ﹤0.01% 2040
2017
Q4 		– Sell
-2,418
Closed -$203K – 2106
2017
Q3 		$203K Buy
+2,418
New +$171K ﹤0.01% 1817
2017
Q2 		– Sell
-2,968
Closed -$216K – 1930
2017
Q1 		$216K Sell
2,968
-2,418
-45% -$159K ﹤0.01% 1568
2016
Q4 		$316K Buy
+5,386
New +$284K 0.01% 1241

Other funds holding ADNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Cambridge Investment Research Advisors's ADNT Position: Q2 2024 in Review

Cambridge Investment Research Advisors sold out of Adient (ADNT) in Q2 2024, closing a stake of 19,645 shares — an estimated $647K sold.

Cambridge Investment Research Advisors first reported a position in ADNT in Q4 2016 and held it in 4 quarters. The position peaked at $647K in Q1 2024. 279 funds tracked by Wall St. Rank hold ADNT as of Q2 2024.

  • Cambridge Investment Research Advisors reported no remaining Adient position as of Q2 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 19,645 Adient shares in Q2 2024, an estimated $647K.
  • Cambridge Investment Research Advisors first reported a position in Adient in Q4 2016 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Adient position peaked at $647K in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Adient as of Q2 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.